InvestorsHub Logo
Followers 14
Posts 1305
Boards Moderated 0
Alias Born 06/05/2007

Re: None

Friday, 05/21/2021 6:58:36 PM

Friday, May 21, 2021 6:58:36 PM

Post# of 7211
PMN.TO (ARFXF in US) is looking really good based on solid news releases over the last 2 months as well as due diligence shared on stockhouse board

They have a 50-50 JV called immusafe that is about to launch its first product- a COVID serology test that claims to be the best in class. details at covidimmunitypassport.com

They are scaling up production of highly selective antibody for Alzheimer's treatment that is a lot better than Biogen's aducanumab. They should start PhI trials this year and recently attracted a $7M investment from the owners of the Boston Red Sox and New England Patriots who have close connections to Alzheimer's cure development. The director of their scientific advisory panel is a bigshot from Harvard.


As far as pennies go- this one is closer to gold than copper. do your own research. These are my personal opinions and not financial advice.

promisneurosciences.com

God grant me the serenity to deal with the things I cannot change; courage to change the things I can and should; and wisdom to know the difference.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.